Medicine & Life Sciences
Metabolomics
100%
Gastrointestinal Microbiome
71%
Microbiota
67%
Aryl Hydrocarbon Receptors
43%
Bile Acids and Salts
39%
Mass Spectrometry
28%
Liver
28%
Diet
26%
Non-alcoholic Fatty Liver Disease
20%
Homeostasis
19%
Peroxisome Proliferator-Activated Receptors
16%
Metabolome
16%
Liquid Chromatography
15%
Lipid Metabolism
14%
Obesity
14%
tempol
13%
Biomarkers
13%
Dysbiosis
13%
Ceramides
13%
Fatty Acids
12%
High Fat Diet
12%
Inflammation
11%
Radiation
11%
Bacteria
11%
Lipids
11%
Intestines
10%
Xenobiotics
10%
Lipogenesis
10%
Serum
10%
Urine
10%
Carcinogenesis
9%
Neoplasms
9%
perfluorooctane sulfonic acid
9%
Ligands
9%
Environmental Pollutants
9%
Fermentation
9%
Glycine
9%
Metabolic Diseases
8%
Pharmaceutical Preparations
8%
Genes
8%
Liver Diseases
8%
choloylglycine hydrolase
8%
Selenoproteins
8%
Colitis
8%
Gene Expression
8%
Milk
8%
Radiation Exposure
7%
Agaricales
7%
2,3,7,8-tetrachlorodibenzofuran
7%
Chemical Compounds
Pharmacological Metabolism
45%
Metabolic
39%
Metabolite
19%
Bile Acid
16%
Hydrocarbon
16%
Lipid
13%
Biological Marker
11%
Glucose
10%
Xenobiotic Agent
9%
Perfluorooctane
9%
Drug
9%
Fatty Acid
8%
Persistent Organic Pollutant
7%
2,3,7,8-Tetrachlorodibenzofuran
6%
Mass Spectrometry
6%
Bile Salt
6%
Biosynthesis
6%
Agent Interacting With Transmitter, Hormone or Drug Receptor
6%
Environmental Substance
6%
Acid
6%
Disorder
5%
Short-Chain Fatty Acid
5%
Polychlorobiphenyl
5%
Sulfonate
5%
Electrospray Ionization
5%
Quadrupole
5%